Restricted accessResearch articleFirst published online 2019-04
A Cross Talk Between BRG1 and Males Absent on the First Contributes to Reactive Oxygen Species Production in a Mouse Model of Nonalcoholic Steatohepatitis
Accumulation of reactive oxygen species (ROS) in hepatocytes in response to excessive nutrients and the ensuing liver damages caused by ROS constitute a key pathophysiological event in nonalcoholic steatohepatitis (NASH). In the present study, we investigated the epigenetic mechanism underlying ROS production in NASH pathogenesis.
Results:
NASH was induced by feeding the mice with a methionine-and-choline-deficient (MCD) diet for 4 weeks. Compared with the control mice (wild type [WT]), mice with hepatocyte-specific deletion of Brg1 (HepcKO), a core component of the mammalian chromatin remodeling complex, developed a less severe form of NASH when fed on the MCD diet. Importantly, ROS levels were attenuated in HepcKO mice as opposed to WT mice. Brahma-related gene 1 (Brg1) deficiency downregulated the transcription of NADPH oxidases (NOX1, NOX2, and NOX4) both in vivo and in vitro. Mechanistically, Brg1 deletion rendered a more repressive chromatin structure surrounding the NOX promoters as characterized by reduced levels of acetylated histones. In addition, Brg1 interacted with the histone H4K16 acetyltransferase males absent on the first (MOF) to activate NOX transcription. MOF knockdown by small interfering RNA or pharmaceutical inhibition by MG149 suppressed NOX transcription and ameliorated ROS levels.
Innovation:
Our data highlight a novel epigenetic mechanism through which Brg1 and MOF cooperate to regulate ROS production in hepatocytes in response to pro-NASH stimuli.
Conclusion:
A cross talk between Brg1 and MOF epigenetically activates NOX transcription and elevates ROS synthesis contributing to NASH pathogenesis.
Get full access to this article
View all access options for this article.
References
1.
AlexanderJM, HotaSK, HeD, ThomasS, HoL, PennacchioLA, and BruneauBG. Brg1 modulates enhancer activation in mesoderm lineage commitment. Development, 142: 1418–1430, 2015.
2.
AoyamaT, PaikYH, WatanabeS, LaleuB, GagginiF, Fioraso-CartierL, MolangoS, HeitzF, MerlotC, SzyndralewiezC, PageP, and BrennerDA. Nicotinamide adenine dinucleotide phosphate oxidase in experimental liver fibrosis: GKT137831 as a novel potential therapeutic agent. Hepatology, 56: 2316–2327, 2012.
3.
ArakawaN, KatsuyamaM, MatsunoK, UraoN, TabuchiY, OkigakiM, MatsubaraH, and Yabe-NishimuraC. Novel transcripts of Nox1 are regulated by alternative promoters and expressed under phenotypic modulation of vascular smooth muscle cells. Biochem J, 398: 303–310, 2006.
4.
AvvakumovN and CoteJ. The MYST family of histone acetyltransferases and their intimate links to cancer. Oncogene, 26: 5395–5407, 2007.
5.
BanerjeeR, BultmanSJ, HolleyD, HillhouseC, BainJR, NewgardCB, MuehlbauerMJ, and WillisMS. Non-targeted metabolomics of double-mutant cardiomyocytes reveals a novel role for SWI/SNF complexes in metabolic homeostasis. Metabolomics, 11: 1287–1301, 2015.
6.
BedardK and KrauseKH. The NOX family of ROS-generating NADPH oxidases: physiology and pathophysiology. Physiol Rev, 87: 245–313, 2007.
7.
BegricheK, MassartJ, RobinMA, BonnetF, and FromentyB. Mitochondrial adaptations and dysfunctions in nonalcoholic fatty liver disease. Hepatology, 58: 1497–1507, 2013.
8.
BettaiebA, JiangJX, SasakiY, ChaoTI, KissZ, ChenX, TianJ, KatsuyamaM, Yabe-NishimuraC, XiY, SzyndralewiezC, SchroderK, ShahA, BrandesRP, HajFG, and TorokNJ. Hepatocyte nicotinamide adenine dinucleotide phosphate reduced oxidase 4 regulates stress signaling, fibrosis, and insulin sensitivity during development of steatohepatitis in mice. Gastroenterology, 149: 468–480.e10, 2015.
9.
BultmanS, GebuhrT, YeeD, La MantiaC, NicholsonJ, GilliamA, RandazzoF, MetzgerD, ChambonP, CrabtreeG, and MagnusonT. A Brg1 null mutation in the mouse reveals functional differences among mammalian SWI/SNF complexes. Mol Cell, 6: 1287–1295, 2000.
10.
BultmanSJ, HolleyDW, de RidderG, PizzoSV, SidorovaTN, MurrayKT, JensenBC, WangZ, BevilacquaA, ChenX, QuintanaMT, TannuM, RossonGB, PandyaK, and WillisMS. BRG1 and BRM SWI/SNF ATPases redundantly maintain cardiomyocyte homeostasis by regulating cardiomyocyte mitophagy and mitochondrial dynamics in vivo. Cardiovasc Pathol, 25: 258–269, 2016.
11.
Carmona-CuencaI, RonceroC, SanchoP, CajaL, FaustoN, FernandezM, and FabregatI. Upregulation of the NADPH oxidase NOX4 by TGF-beta in hepatocytes is required for its pro-apoptotic activity. J Hepatol, 49: 965–976, 2008.
DufourJF, OnetaCM, GonversJJ, BihlF, CernyA, CeredaJM, ZalaJF, HelblingB, SteuerwaldM, and ZimmermannA. Randomized placebo-controlled trial of ursodeoxycholic acid with vitamin e in nonalcoholic steatohepatitis. Clin Gastroenterol Hepatol, 4: 1537–1543, 2006.
14.
EzquerM, EzquerF, RiccaM, AllersC, and CongetP. Intravenous administration of multipotent stromal cells prevents the onset of non-alcoholic steatohepatitis in obese mice with metabolic syndrome. J Hepatol, 55: 1112–1120, 2011.
15.
FanJG and FarrellGC. Epidemiology of non-alcoholic fatty liver disease in China. J Hepatol, 50: 204–210, 2009.
16.
FanZ, HaoC, LiM, DaiX, QinH, LiJ, XuH, WuX, ZhangL, FangM, ZhouB, TianW, and XuY. MKL1 is an epigenetic modulator of TGF-beta induced fibrogenesis. Biochim Biophys Acta, 1849: 1219–1228, 2015.
17.
FangF, ChenD, YuL, DaiX, YangY, TianW, ChengX, XuH, WengX, FangM, ZhouJ, GaoY, ChenQ, and XuY. Proinflammatory stimuli engage brahma related gene 1 and brahma in endothelial injury. Circ Res, 113: 986–996, 2013.
18.
FarrellGC and LarterCZ. Nonalcoholic fatty liver disease: from steatosis to cirrhosis. Hepatology, 43: S99–S112, 2006.
19.
FuLL, TianM, LiX, LiJJ, HuangJ, OuyangL, ZhangY, and LiuB. Inhibition of BET bromodomains as a therapeutic strategy for cancer drug discovery. Oncotarget, 6: 5501–5516, 2015.
20.
GebuhrTC, KovalevGI, BultmanS, GodfreyV, SuL, and MagnusonT. The role of Brg1, a catalytic subunit of mammalian chromatin-remodeling complexes, in T cell development. J Exp Med, 198: 1937–1949, 2003.
21.
GlarosS, CirrincioneGM, PalancaA, MetzgerD, and ReismanD. Targeted knockout of BRG1 potentiates lung cancer development. Cancer Res, 68: 3689–3696, 2008.
22.
GuptaA, SharmaGG, YoungCS, AgarwalM, SmithER, PaullTT, LucchesiJC, KhannaKK, LudwigT, and PanditaTK. Involvement of human MOF in ATM function. Mol Cell Biol, 25: 5292–5305, 2005.
23.
HangCT, YangJ, HanP, ChengHL, ShangC, AshleyE, ZhouB, and ChangCP. Chromatin regulation by Brg1 underlies heart muscle development and disease. Nature, 466: 62–67, 2010.
24.
HarrisonSA, TorgersonS, HayashiP, WardJ, and SchenkerS. Vitamin E and vitamin C treatment improves fibrosis in patients with nonalcoholic steatohepatitis. Am J Gastroenterol, 98: 2485–2490, 2003.
25.
KlegerA, MahaddalkarPU, KatzSF, LechelA, JooJY, LoyaK, LinQ, HartmannD, LiebauS, KrausJM, CantzT, KestlerHA, ZaehresH, ScholerH, and RudolphKL. Increased reprogramming capacity of mouse liver progenitor cells, compared with differentiated liver cells, requires the BAF complex. Gastroenterology, 142: 907–917, 2012.
26.
KleinerDE, BruntEM, Van NattaM, BehlingC, ContosMJ, CummingsOW, FerrellLD, LiuYC, TorbensonMS, Unalp-AridaA, YehM, McCulloughAJ, and SanyalAJ. Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology, 41: 1313–1321, 2005.
27.
LanT, KisselevaT, and BrennerDA. Deficiency of NOX1 or NOX4 prevents liver inflammation and fibrosis in mice through inhibition of hepatic stellate cell activation. PLoS One, 10: e0129743, 2015.
28.
LiZY, YangJ, GaoX, LuJY, ZhangY, WangK, ChengMB, WuNH, WuZ, and ShenYF. Sequential recruitment of PCAF and BRG1 contributes to myogenin activation in 12-O-tetradecanoylphorbol-13-acetate-induced early differentiation of rhabdomyosarcoma-derived cells. J Biol Chem, 282: 18872–18878, 2007.
29.
MarchesiniG, PettaS, and Dalle GraveR. Diet, weight loss, and liver health in nonalcoholic fatty liver disease: pathophysiology, evidence, and practice. Hepatology, 63: 2032–2043, 2016.
30.
MujtabaS, ZengL, and ZhouMM. Structure and acetyl-lysine recognition of the bromodomain. Oncogene, 26: 5521–5527, 2007.
31.
NaiduSR, LoveIM, ImbalzanoAN, GrossmanSR, and AndrophyEJ. The SWI/SNF chromatin remodeling subunit BRG1 is a critical regulator of p53 necessary for proliferation of malignant cells. Oncogene, 28: 2492–2501, 2009.
32.
PaikYH, IwaisakoK, SekiE, InokuchiS, SchnablB, OsterreicherCH, KisselevaT, and BrennerDA. The nicotinamide adenine dinucleotide phosphate oxidase (NOX) homologues NOX1 and NOX2/gp91(phox) mediate hepatic fibrosis in mice. Hepatology, 53: 1730–1741, 2011.
33.
PandayA, SahooMK, OsorioD, and BatraS. NADPH oxidases: an overview from structure to innate immunity-associated pathologies. Cell Mol Immunol, 12: 5–23, 2015.
34.
Perez-CarrerasM, Del HoyoP, MartinMA, RubioJC, MartinA, CastellanoG, ColinaF, ArenasJ, and Solis-HerruzoJA. Defective hepatic mitochondrial respiratory chain in patients with nonalcoholic steatohepatitis. Hepatology, 38: 999–1007, 2003.
35.
RoyN, MalikS, VillanuevaKE, UranoA, LuX, Von FiguraG, SeeleyES, DawsonDW, CollissonEA, and HebrokM. Brg1 promotes both tumor-suppressive and oncogenic activities at distinct stages of pancreatic cancer formation. Genes Dev, 29: 658–671, 2015.
36.
SalmaN, XiaoH, MuellerE, and ImbalzanoAN. Temporal recruitment of transcription factors and SWI/SNF chromatin-remodeling enzymes during adipogenic induction of the peroxisome proliferator-activated receptor gamma nuclear hormone receptor. Mol Cell Biol, 24: 4651–4663, 2004.
37.
SekiS, KitadaT, YamadaT, SakaguchiH, NakataniK, and WakasaK. In situ detection of lipid peroxidation and oxidative DNA damage in non-alcoholic fatty liver diseases. J Hepatol, 37: 56–62, 2002.
38.
StarleyBQ, CalcagnoCJ, and HarrisonSA. Nonalcoholic fatty liver disease and hepatocellular carcinoma: a weighty connection. Hepatology, 51: 1820–1832, 2010.
39.
SunL, LiH, ChenJ, DehennautV, ZhaoY, YangY, IwasakiY, Kahn-PerlesB, LePrinceD, ChenQ, ShenA, and XuY. A SUMOylation dependent pathway regulates SIRT1 transcription and cancer metastasis. J Nat Cancer Inst, 105: 887–898, 2013.
40.
TanK, FujimotoM, TakiiR, TakakiE, HayashidaN, and NakaiA. Mitochondrial SSBP1 protects cells from proteotoxic stresses by potentiating stress-induced HSF1 transcriptional activity. Nat Commun, 6: 6580, 2015.
41.
TianW, FanZ, LiJ, HaoC, LiM, XuH, WuX, ZhouB, ZhangL, FangM, and XuY. Myocardin-related transcription factor A (MRTF-A) plays an essential role in hepatic stellate cell activation by epigenetically modulating TGF-beta signaling. Int J Biochem Cell Biol, 71: 35–43, 2016.
42.
TianW, HaoC, FanZ, WengX, QinH, WuX, FangM, ChenQ, ShenA, and XuY. Myocardin related transcription factor A programs epigenetic activation of hepatic stellate cells. J Hepatol, 62: 165–174, 2015.
43.
TianW, XuH, FangF, ChenQ, XuY, and ShenA. Brahma-related gene 1 bridges epigenetic regulation of proinflammatory cytokine production to steatohepatitis in mice. Hepatology, 58: 576–588, 2013.
44.
WangY, WongRH, TangT, HudakCS, YangD, DuncanRE, and SulHS. Phosphorylation and recruitment of BAF60c in chromatin remodeling for lipogenesis in response to insulin. Mol Cell, 49: 283–297, 2013.
45.
WengX, YuL, LiangP, LiL, DaiX, ZhouB, WuX, XuH, FangM, ChenQ, and XuY. A crosstalk between chromatin remodeling and histone H3K4 methyltransferase complexes in endothelial cells regulates angiotensin II-induced cardiac hypertrophy. J Mol Cell Cardiol, 82: 48–58, 2015.
46.
WilliamsR. Global challenges in liver disease. Hepatology, 44: 521–526, 2006.
47.
XuW, XuH, FangM, WuX, and XuY. MKL1 links epigenetic activation of MMP2 to ovarian cancer cell migration and invasion. Biochem Biophys Res Commun, 487: 500–508, 2017.
48.
XuY and FangF. Regulatory role of Brg1 and Brm in the vasculature: from organogenesis to stress-induced cardiovascular disease. Cardiovasc Hematol Disord Drug Targets, 12: 141–145, 2012.
49.
YangL, RohYS, SongJ, ZhangB, LiuC, LoombaR, and SekiE. Transforming growth factor beta signaling in hepatocytes participates in steatohepatitis through regulation of cell death and lipid metabolism in mice. Hepatology, 59: 483–495, 2014.
50.
YangY, ChenD, YuanZ, FangF, ChengX, XiaJ, FangM, XuY, and GaoY. Megakaryocytic leukemia 1 (MKL1) ties the epigenetic machinery to hypoxia-induced transactivation of endothelin-1. Nucleic Acids Res, 41: 6005–6017, 2013.
51.
ZhouB, ZengS, LiL, FanZ, TianW, LiM, XuH, WuX, FangM, and XuY. Angiogenic factor with G patch and FHA domains 1 (Aggf1) regulates liver fibrosis by modulating TGF-beta signaling. Biochim Biophys Acta, 1862: 1203–1213, 2016.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
